Ery-Ped Drug Interactions: 70 Major, 1116 Moderate
Ery-Ped (Erythromycin Ethylsuccinate) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ery-Ped. Always confirm against the full prescribing information.
100 interactions
Abacavir
The risk or severity of liver damage can be increased when Erythromycin is combined with Abacavir.
Level 2 evidence
Abatacept
The metabolism of Erythromycin can be increased when combined with Abatacept.
Level 1 evidence
Abemaciclib
The serum concentration of Abemaciclib can be increased when it is combined with Erythromycin.
Level 1 evidence
Abiraterone
The serum concentration of Abiraterone can be increased when it is combined with Erythromycin.
Level 1 evidence
Acalabrutinib
The serum concentration of Acalabrutinib can be increased when it is combined with Erythromycin.
Level 1 evidence
Acamprosate
The risk or severity of liver damage can be increased when Erythromycin is combined with Acamprosate.
Level 2 evidence
Acarbose
The risk or severity of liver damage can be increased when Erythromycin is combined with Acarbose.
Level 2 evidence
Acebutolol
The risk or severity of liver damage can be increased when Erythromycin is combined with Acebutolol.
Level 2 evidence
Aceclofenac
The risk or severity of liver damage can be increased when Erythromycin is combined with Aceclofenac.
Level 2 evidence
Acenocoumarol
The risk or severity of bleeding can be increased when Erythromycin is combined with Acenocoumarol.
Level 1 evidence
Acetaminophen
The serum concentration of Acetaminophen can be increased when it is combined with Erythromycin.
Level 1 evidence
Acetazolamide
The risk or severity of liver damage can be increased when Erythromycin is combined with Acetazolamide.
Level 2 evidence
Enter your NPI to unlock 6 major interactions for Ery-Ped
Ery-Ped (Erythromycin Ethylsuccinate) has 1238 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Ery-Ped (Erythromycin Ethylsuccinate) has 70 major, 1116 moderate, and 52 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ery-Ped. Always confirm against the full prescribing information.